Could Clover Health Be a Millionaire-Maker Stock?
Clover Health (NASDAQ: CLOV) made a big splash on Jan. 8 when it went public through a SPAC backed by Chamath Palihapitiya, the CEO of Social Capital and an early senior executive at Facebook. The Medicare Advantage insurer's stock, however, is down 45% since then, after suffering a double whammy of bad news in early February.
Does this spell trouble for the young public company, or is the dip in its stock an opportunity to buy shares today and become a millionaire tomorrow?
Image source: Getty Images
Source Fool.com
